These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15467385)

  • 1. Effects of Ca2+ -sensitizers in permeabilized cardiac myocytes from donor and end-stage failing human hearts.
    Papp Z; Van Der Velden J; Borbély A; Edes I; Stienen GJ
    J Muscle Res Cell Motil; 2004; 25(3):219-24. PubMed ID: 15467385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins.
    van der Velden J; Papp Z; Zaremba R; Boontje NM; de Jong JW; Owen VJ; Burton PB; Goldmann P; Jaquet K; Stienen GJ
    Cardiovasc Res; 2003 Jan; 57(1):37-47. PubMed ID: 12504812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Ca2+ signaling and Ca2+ sensitizers.
    Endoh M
    Circ J; 2008 Dec; 72(12):1915-25. PubMed ID: 18981594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of calcium, inorganic phosphate, and pH on isometric force in single skinned cardiomyocytes from donor and failing human hearts.
    van Der Velden J; Klein LJ; Zaremba R; Boontje NM; Huybregts MA; Stooker W; Eijsman L; de Jong JW; Visser CA; Visser FC; Stienen GJ
    Circulation; 2001 Sep; 104(10):1140-6. PubMed ID: 11535570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive inotropic effects of calcium sensitizers on normal and failing cardiac myocytes.
    Tsutsui H; Kinugawa S; Ide T; Hayashidani S; Suematsu N; Satoh S; Nakamura R; Egashira K; Takeshita A
    J Cardiovasc Pharmacol; 2001 Jan; 37(1):16-24. PubMed ID: 11152370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EMD 53998 acts as Ca(2+)-sensitizer and phosphodiesterase III-inhibitor in human myocardium.
    Uhlmann R; Schwinger RH; Lues I; Erdmann E
    Basic Res Cardiol; 1995; 90(5):365-71. PubMed ID: 8585857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of myosin light chain 2 dephosphorylation on Ca2+ -sensitivity of force is enhanced in failing human hearts.
    van der Velden J; Papp Z; Boontje NM; Zaremba R; de Jong JW; Janssen PM; Hasenfuss G; Stienen GJ
    Cardiovasc Res; 2003 Feb; 57(2):505-14. PubMed ID: 12566123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Ca2+ sensitizers on contraction, [Ca2+]i transient and myofilament Ca2+ sensitivity in diabetic rat myocardium: potential usefulness as inotropic agents.
    Ishitani T; Hattori Y; Sakuraya F; Onozuka H; Makino T; Matsuda N; Gando S; Kemmotsu O
    J Pharmacol Exp Ther; 2001 Aug; 298(2):613-22. PubMed ID: 11454923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of calcium sensitizers on intracellular calcium handling and myocardial energetics.
    Hasenfuss G; Pieske B; Kretschmann B; Holubarsch C; Alpert NR; Just H
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S45-51. PubMed ID: 8907130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered myocardial force generation in end-stage human heart failure.
    Papp Z; van der Velden J; Borbély A; Édes I; Stienen GJM
    ESC Heart Fail; 2014 Dec; 1(2):160-165. PubMed ID: 28834631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca++ sensitizers impair cardiac relaxation in failing human myocardium.
    Hajjar RJ; Schmidt U; Helm P; Gwathmey JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):247-54. PubMed ID: 8996203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes.
    Kinugawa S; Tsutsui H; Ide T; Nakamura R; Arimura K; Egashira K; Takeshita A
    Cardiovasc Res; 1999 Jul; 43(1):157-64. PubMed ID: 10536700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel cardiotonic agent EMD 53 998 is a potent "calcium sensitizer".
    Beier N; Harting J; Jonas R; Klockow M; Lues I; Haeusler G
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):17-27. PubMed ID: 1719287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium sensitivity of force in human ventricular cardiomyocytes from donor and failing hearts.
    van der Velden J; Boontje NM; Papp Z; Klein LJ; Visser FC; de Jong JW; Owen VJ; Burton PB; Stienen GJ
    Basic Res Cardiol; 2002; 97 Suppl 1():I118-26. PubMed ID: 12479245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca2+ sensitization in idiopathic dilated human myocardium. Differential in vitro effects of (+)-(5-methyl-6-phenyl)-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazoci ne-2,4-dione, a novel purely Ca2+sensitizing agent, and (+)-5-(1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydroquinolin-6-yl)-6-meth yl-3, 6-dihydro-2H-1,3,4-thiadiazin-2-one on skinned fibres and isolated ventricular strips.
    Herzig JW; Chiesi M; Depersin H; Grüninger S; Hasenfuss G; Kubalek R; Leutert T; Pieske B; Pioch K; Wenk P; Holubarsch C
    Arzneimittelforschung; 1996 Jun; 46(6):586-93. PubMed ID: 8767348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the Ca2+ sensitizers EMD 57033 and CGP 48506 on myocardial contractility and Ca2+ transients in human ventricular and atrial myocardium.
    Brixius K; Reicke S; Reuter H; Schwinger RH
    Z Kardiol; 2002 Apr; 91(4):312-8. PubMed ID: 12063703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein phosphatase 2A affects myofilament contractility in non-failing but not in failing human myocardium.
    Wijnker PJ; Boknik P; Gergs U; Müller FU; Neumann J; dos Remedios C; Schmitz W; Sindermann JR; Stienen GJ; van der Velden J; Kirchhefer U
    J Muscle Res Cell Motil; 2011 Nov; 32(3):221-33. PubMed ID: 21959857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The two mechanisms of action of racemic cardiotonic EMD 53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers.
    Lues I; Beier N; Jonas R; Klockow M; Haeusler G
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):883-92. PubMed ID: 7687712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of protein kinase A on calcium sensitivity of force and its sarcomere length dependence in human cardiomyocytes.
    van der Velden J; de Jong JW; Owen VJ; Burton PB; Stienen GJ
    Cardiovasc Res; 2000 Jun; 46(3):487-95. PubMed ID: 10912459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium sensitization as new principle of inotropic therapy in end-stage heart failure?
    Zimmermann N; Boknik P; Gams E; Herzig JW; Neumann J; Scholz H
    Eur J Cardiothorac Surg; 1998 Jul; 14(1):70-5. PubMed ID: 9726618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.